Skip to contents

  2. Kubasch, Anne Sophie [Author]; Peterlin, P. [Author]; Cluzeau, T. [Author]; Götze, K. S. [Author]; Sockel, K. [Author]; Teipel, R. [Author]; Jentzsch, M. [Author]; Attalah, H. [Author]; Sebert, M. [Author]; Chermat, F. [Author]; Gloaguen, S. [Author]; Puttrich, M. [Author]; Cross, M. [Author]; Schneider, M. [Author]; Kayser, Sabine [Author]; Schipp, D. [Author]; Giagounidis, A. [Author]; Tirado-Gonzalez, I. [Author]; Descot, A. [Author]; van de Loosdrecht, A. [Author]; Weigert, A. [Author]; Metzeler, K. H. [Author]; Fenaux, P. [Author]; Medyouf, H. [Author]; [...]

    Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial

    Articles
    View online
    Schließen
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    21 September 2023

    Published in: Leukemia ; 37(2023), 11, Seite 2309-2313

  5. Oza, A.M.; Plummer, R.; Vergote, I.B.; Thistlethwaite, F.; Bjarnason, G.A.; Jones, R.J.; Mackay, H.; Van Cutsem, E.; Faivre, S.; Descot, C.; Germann, N.; Escudier, B.

    Phase Ii, Multicenter, Open-Label, Proof of Concept Study of Tasquinimod in Patients with Advanced Hepatocellular (Hcc), Ovarian (Oc), Renal Cell (Rcc) and Gastric (Gc) Carcinomas

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2014

    Published in: Annals of Oncology

  6. Kubasch, A. S.; Peterlin, P.; Cluzeau, T.; Götze, K. S.; Sockel, K.; Teipel, R.; Jentzsch, M.; Attalah, H.; Sebert, M.; Chermat, F.; Gloaguen, S.; Puttrich, M.; Cross, M.; Schneider, M.; Kayser, S.; Schipp, D.; Giagounidis, A.; Tirado-Gonzalez, I.; Descot, A.; van de Loosdrecht, A.; Weigert, A.; Metzeler, K. H.; Fenaux, P.; Medyouf, H.; [...]

    Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Springer Science and Business Media LLC, 2023

    Published in: Leukemia